Anileridine hydrochloride

This classification denotes an opioid receptor agonist and opioid with the molecular formula C22H28N2O2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 915Q054DLC, chemically known as 4-piperidinecarboxylic acid, 1-(2-(4-aminophenyl)ethyl)-4-phenyl-, ethyl ester, dihydrochloride but more generally known as anileridine hydrochloride, which bears US NIH Compound Identifier 31338. European Medicines Agency schedules Anileridine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00532MIG. Most nations, for tariff and trade purposes, schedule anileridine hydrochloride under HS 29333300 and SITC 51574. As of Q4 2014, ANILERIDINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Anileridine hydrochloride bears US NLM identifiers UMLS ID C0770427 and NCI Concept Code C65235. SMILES: CCOC(=O)C1(CCN(CC1)CCC2CCC(CC2)N)C3CCCCC3.CL.CL.